Overview

A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease

Status:
Terminated

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

This is a study to evaluate the safety, tolerability and blood levels of PF-03654746 in subjects will mild to moderate Alzheimer's disease.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer